Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function

Journal of Clinical Neuroscience

Volumn 15, Issue 11, 2008, Pages 1264-1269

  Zhao, Yejun ^a   Sun, Lena ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Antidepressant medication; HEK hNET transfected cells; HEK hSERT transfected cells; Human embryonic kidney 293 cells; Intravenous anesthetics; NET transporter; SERT transporter

Indexed keywords

DESIPRAMINE; ETOMIDATE; FLUOXETINE; KETAMINE; NORADRENALIN TRANSPORTER; PROPOFOL; SEROTONIN; SEROTONIN TRANSPORTER; THIOPENTAL;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANALGESICS; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; CELL LINE, TRANSFORMED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPISTASIS, GENETIC; HUMANS; KETAMINE; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PROPOFOL; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRANSFECTION; TRITIUM;

EID: 53349163279     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.11.007     Document Type: Article

References (23)

1. Amara S.G., and Arriza J.L. Neurotransmitter transporter:three distinct gene families. Curr Opin Neurobiol 3 (1993) 337-344
2. Amara S.G., and Kuhar M.J. Neurotransmitter transporters:recent progress. Annu Rev Neurosci 16 (1993) 73-93
3. Barker E.L., and Blackly R.D. Norepinephrine and serotonin transporters. Molecular targets of antidepressant drugs. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology. A Fourth Generation of Progress (1995), Raven Press, New York 321-333
4. Blakely R. Physiological genomics of antidepressant targets: keeping the periphery in mind. J Neurosci 21 (2000) 8319-8323
5. Lucki I., and O'Leary O.F. Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs. J Clin Psychiatry 65 (2004) 11-24
6. Ren Z.G., Porzgen P., Zhang J.M., et al. Autocrine regulation of norepinephrine transporter expression. Mol Cell Neuroscience 17 (2000) 539-550
7. Zhu M.Y., Blakely R.D., Apparsundaram S., et al. Down-regulation of the human norepinephrine transporter in intact 293-hNET cells exposed to desipramine. J Neurochem 70 (1998) 1547-1555
8. 3H]-norepinephrine in the rat brain. J Neurochemistry 18 (1971) 2061-2075
9. Horschitz S., Hummerich E., and Schloss P. Functional coupling of serotonin and nordrenaline transporters. J Neurochemistry 86 (2003) 958-965
10. Ordway G.A., Stockmeier C.A., Cason G.W., et al. Pharmacology and distribution of norepinephrine transporter in the human locus coeruleus and raphe nuclei. J Neuroscience 17 (1997) 1710-1719
11. Stoelting R.T. Pharmacology and Physiology in Anesthetic Practice. 3rd ed. (1999), Lippincott Williams and Wilkins, Philadelphia 140-58
12. Hara K., Yanagihara N., Minami K., et al. Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site. Naunyn-Schmiedeberg's Arch Pharmacol 358 (1998) 328-333
13. Mandela P., and Ordway G.A. The norepinephrine transporter and its regulation. J Neurochemistry 97 (2006) 310-333
14. Nishimura M., Sato K., Okada T., et al. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology 88 (1998) 768-774
15. Shahani S., Lingamaneni R., and Hemmings H.C. General anesthetic actions on norepinephrine, dopamine, and γ-aminobutyric acid transporters in stable transfected cells. Anesth Analg 95 (2002) 893-899
16. Richard C. What the actions of anesthetics on fast synaptic transmission reveal about the molecular mechanisms of anesthesia. Toxicol Let 100 (1998) 41-50
17. Gottschling S., Meyer S., Krenn T., et al. Propofol versus midazolam/ketamine for procedural sedation in pediatric oncology. J Pediatr Hemotol Oncol 27 (2005) 471-476
18. Weinshenker D., White S., Javors M., et al. Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo. Brain Research 946 (2002) 239-246
19. Vizi E.S., Zsilla G., and Caron M.G. Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice:implications for the action of selective serotonin reuptake inhibitors. J Neuroscience 24 (2004) 7888-7894
20. Shannon J.R., Flattem N.L., Jordan J., et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342 (2000) 541-549
21. Montanez S., Daws L.C., Gould G.G., et al. Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons. J Neurochem 87 (2003) 861-867
22. Martin D.C., Introna R.P., and Aronstam R.S. Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter. Neurosci Lett 112 (1990) 99-103
23. Yoshimura R, Yanagihara N, Hara K, et al. Inhibitory effects of clonzapine and other antipsychotic drugs on noradrenaline transporter in cultured bovine adrenal medullary cells. Psychophamacology 2000;149:17-23.